Y-a-t-il une place pour la chirurgie dans les tumeurs urothéliales métastasées ?

25 novembre 2008

Auteurs : T. Lebret, A. Méjean
Référence : Prog Urol, 2008, 18, S285, suppl. S7
   
 
 

 

 
Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser

   

 

 
 
 

Références

 

CCAFU Recommandation du Comité de Cancérologie de l’AFU Prog Urol 2007 ;  17 : 1117-1230
 
Stenzl A., Cowan N.C., De Santis M., Jackse G., Kuczyk M., Merseburger A.S., Ribal M.J., Sherif A., Witjes J.A. Guidelines on bladder cancer, muscle-invasive and metastatic Eau guidelines office 2008, March ; 1-59
 
Bajorin D.F., Dodd P.M., Mazumdar M., Fazzari M., McCaffrey J.A., Scher H.I., Herr H., Higgins G., Boyle M.G. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy J Clin Oncol 1999 ;  17 (10) : 3173-3181 [cross-ref]
 
Iaffaioli R.V., Milano A., Caponigro F. Therapy of metastatic bladder carcinoma Ann Oncol 2007 ;  18 (6) : vi153-vi156
 
Sternberg C.N., Vogelzang J. Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers Crit Rev Oncol Hematol 2003 ;  46 : S105-S115 [cross-ref]
 
Camey M. How I treat invasive bladder carcinoma Prog Clin Biol Res 1984 ;  162B : 231-235
 
Guzzo T.J., Rogers C.G., Deng C.Y., Bivalacqua T.J., Palapattu G.S., Bastian P.J., Eisenberger M.A., Schoenberg M.P., Gonzalgo M.L. Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease BJU Int 2008 ; Aug 22 [Epub ahead of print].
 
Coptcoat M.J., Oliver R.T. The role of surgery in the multimodality treatment of bladder cancer Cancer Surv 1998 ;  31 : 129-147
 
Dreicer R. Locally advanced and metastatic bladder cancer Curr Treat Options Oncol 2001 ;  2 (5) : 431-436 [cross-ref]
 
Cowles R.S., Johnson D.E., McMurtrey M.J. Long-term results following thoracotomy for metastatic bladder cancer Urology 1982 ;  20 (4) : 390-392 [cross-ref]
 
Dodd P.M., McCaffrey J.A., Herr H., Mazumdar M., Bacik J., Higgins G., Boyle M.G., Scher H.I., Bajorin D.F. Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma J Clin Oncol 1999 ;  17 (8) : 2546-2552
 
Miller R.S., Freiha F.S., Reese J.H., Ozen H., Torti F.M. Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium J Urol 1993 ;  150 (1) : 65-69 [cross-ref]
 
Dimopoulos M.A., Finn L., Logothetis C.J. Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy J Urol 1994 ;  151 (3) : 598-600discussion 600-1.  [cross-ref]
 
Siefker-Radtke A.O., Walsh G.L., Pisters L.L., Shen Y., Swanson D.A., Logothetis C.J., Millikan R.E. Is there a role for surgery in the management of metastatic urothelial cancer? The M D. Anderson experience J Urol 2004 ;  171 (1) : 145-148 [cross-ref]
 
Sternberg C.N., de Mulder P., Schornagel J.H., et al. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours Eur J Cancer 2006 ;  42 (1) : 50-54 [cross-ref]
 
von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 200520 23(21):4602-8.
 
Ruggeri E.M., Giannarelli D., Bria E., Carlini P., Felici A., Nelli F., Gallucci M., Cognetti F., Pollera C.F. Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies Cancer 2006 ;  106 (4) : 783-788 [cross-ref]
 
Bamias A., Tikiakos I., Karali M.D., Dimopoulos M.A. Systemic chemotherapy in inoperable or metastatic bladder cancer Ann. Oncol 2006 ;  17 (4) : 553-561 [cross-ref]
 
Herr H.W., Donat S.M., Bajorin D.F. Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer J Urol 2001 ;  165 (3) : 811-814 [cross-ref]
 
Otto T., Krege S., Suhr J., Rübben H. Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial Urology 2001 ;  57 (1) : 55-59 [inter-ref]
 
Sternberg C.N. Muscle invasive and metastatic bladder cancer Ann Oncol 2006 ;  17 (10) : 23-30
 
Jónsson B., Sjöström L., Olerud C., Andréasson I., Bring J., Rauschning W. Outcome after limited posterior surgery for thoracic and lumbar spine metastases Eur Spine J 1996 ;  5 (1) : 36-44
 
Chu D.Z., Lang N.P., Thompson C., Osteen P.K., Westbrook K.C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors Cancer 1989 ;  63 (2) : 364-367 [cross-ref]
 
Mead G.M., Russell M., Clark P., Harland S.J., Harper P.G., Cowan R., Roberts J.T., Uscinska B.M., Griffiths G.O., Parmar M.K. A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party Br J Cancer 1998 ;  78 (8) : 1067-1075 [cross-ref]
 
Otto T., Suhr J., Krege S., Goebell P.J., Wishahi M., Bier U.W., Kimmig R., Rübben H. Surgical treatment of disseminated peritoneal metastases from urological cancer: results from a prospective study BJU Int 2002 ;  90 (9) : 823-827 [cross-ref]
 
Edwards W.H., Sawyers J.L., Adkins R.B. Major hepatic resection: an update South Med J 1990 ;  83 (1) : 18-22 [cross-ref]
 
Tanis P.J., Zondervan P., van de Wiel B.A., van Tets W.F. Surgery for isolated lung metastasis in two patients with bladder cancer Urology 2005 ;  66 (4) : 881
 
Loehrer P.J., Einhorn L.H., Elson P.J., Crawford E.D., Kuebler P., Tannock I., Raghavan D., Stuart Harris R., Sarosdy M.F., Lowe B.A., et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 1992 ;  10 (7) : 1066-1073 [cross-ref]
 
Rasco D.W., Assikis V., Marshall F. Integrating metastasectomy in the management of advanced urological malignancies-where are we in 2005? J Urol 2006 ;  176 (5) : 1921-1926 [cross-ref]
 
   
 
 
   

 

© 2008  Elsevier Masson SAS. Tous droits réservés.